Reduced-volume vs conventional-volume radiotherapy after induction chemotherapy in nasopharyngeal carcinoma
Melvin LK Chua, Clinician-Scientist at the NCCS and Duke-NUS Medical School, shared on X about recent paper by Ling-Long Tang et al., titled “Reduced-volume radiotherapy versus conventional-volume radiotherapy after induction chemotherapy in nasopharyngeal carcinoma: An open-label, noninferiority, multicenter, randomized phase 3 trial” published on ACS Journals.
Authors: Ling-Long Tang, Lin Chen, Gui-Qiong Xu, Ning Zhang, Cheng-Long Huang, Wen-Fei Li, Yan-Ping Mao, Guan-Qun Zhou, Feng Lei, Lu-Si Chen, Shao Hui Huang, Lei Chen, Yu-Pei Chen, Yuan Zhang, Xu Liu, Cheng Xu, Yin Zhao, Ji-Bin Li, Na Liu, Fang-Yun Xie, Rui Guo, Ying Sun, Jun Ma
“This may not be ‘practice-changing’ per se but kudos to the investigators for running this trial. I have known Prof Tang for many years now and she is a solid clinician who has prob treated more NPC than most of us (even experts) around the world!
Look out for more publicity on this topic in the coming months!”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023